(1)
Sussman, G.; Hebert, J.; Gulliver, W.; Lynde, C.; Lang, W. H.; Chambenoit, O.; Deutsch, G.; DeTakaosy, F.; Rihakova, L. Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). J of Skin 2018, 2, S51.